ArticleMolecular cancer therapeutics2018

Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers.

Zhihao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.